|
XYLB expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.240000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.160700E-03 |
| Normal-vs-Stage2 |
1.379240E-03 |
| Normal-vs-Stage3 |
2.583800E-01 |
| Normal-vs-Stage4 |
9.995200E-01 |
| Stage1-vs-Stage2 |
2.517800E-01 |
| Stage1-vs-Stage3 |
7.977900E-02 |
| Stage1-vs-Stage4 |
4.018200E-02 |
| Stage2-vs-Stage3 |
2.242300E-02 |
| Stage2-vs-Stage4 |
1.213880E-02 |
| Stage3-vs-Stage4 |
3.631200E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.787500E-02 |
| Normal-vs-AfricanAmerican |
6.306400E-02 |
| Normal-vs-Asian |
4.381600E-03 |
| Caucasian-vs-AfricanAmerican |
5.255400E-01 |
| Caucasian-vs-Asian |
1.772810E-01 |
| AfricanAmerican-vs-Asian |
7.342200E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.577400E-03 |
| Normal-vs-Female |
4.533700E-02 |
| Male-vs-Female |
1.992380E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.623570E-02 |
| Normal-vs-Age(41-60Yrs) |
2.579000E-03 |
| Normal-vs-Age(61-80Yrs) |
4.837000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.418210E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.850600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.523390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.256200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.637500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.896800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.579000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.142190E-02 |
| Classical-VS-Follicular |
2.077700E-02 |
| Classical-VS-Other |
5.014600E-01 |
| Classical-VS-Normal |
5.058200E-02 |
| Tall-VS-Follicular |
6.814000E-04 |
| Tall-VS-Other |
8.235600E-02 |
| Tall-VS-Normal |
3.922400E-01 |
| Follicular-VS-Other |
9.196200E-01 |
| Follicular-VS-Normal |
1.404430E-03 |
| Other-VS-Normal |
1.323380E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.016000E-03 |
| Normal-vs-N1 |
9.129500E-02 |
| N0-vs-N1 |
5.972600E-01 |
|
|
